封面
市场调查报告书
商品编码
1435708

2024 年生物分析测试服务全球市场报告

Bioanalytical Testing Services Global Market Report 2024

出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物分析测试服务的市场规模预计在未来几年将显着成长。预计到 2028 年将以 9.5% 的复合年增长率 (CAGR) 增长至 49.9 亿美元。预测期内的预期成长将由生物製药管道的扩大、生物相似药的开发增加、精准医学的进步以及临床试验复杂性的增加所推动。这段时期的主要趋势包括人工智慧(AI)的整合、综合药物趋势分析、微生物组分析服务、高通量技术的采用和生物样本分析。

旨在控制感染疾病爆发的政府倡议的扩大在推动生物分析测试服务市场的扩张方面发挥关键作用。冠状病毒感染疾病(COVID-19)大流行的爆发对生物分析检测服务提出了特别的需求,世界各国正在采取积极措施防止该疾病的传播并减少其影响。我们敦促采取行动并增加支出。一个明显的例子是 2021 年 3 月美国卫生与公众服务部的公告,详细说明了美国救援计画投资 100 亿美元,以加强筛检测试,以安全地重新开放学校。此外,还拨款 22.5 亿美元用于扩大对服务不足人口的检测。对政府措施的财政承诺的增强预计将大大促进生物分析测试服务市场的持续成长。

慢性病的日益普及预计将在不久的将来推动生物分析测试服务市场的成长。慢性病的特征是病情持续超过 3 个月,并且会随着时间的推移而恶化,因此需要有效的诊断和监测工具。生物分析测试服务在识别和测量与慢性病相关的特定生物标记方面发挥关键作用,并协助监测治疗药物以确保治疗范围内的最佳药物水平。例如,国家医学图书馆 2023 年 1 月报告称,美国50 岁及以上患有至少一种慢性疾病的人数预计将增加 99.5%,到 2050 年将达到 1.4266 亿。是。世界卫生组织2022年9月发布的2022年重点报告显示,全球每年有4,100万人死亡,其中74%可归因于非传染性疾病(NCD)或慢性病。慢性病盛行率的快速增加是推动生物分析测试服务市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章市场区隔

  • 全球生物分析测试服务市场,按测试类型、性能和预测细分,2018-2023、2023-2028、2033
  • ADME(吸收、分布、代谢、排泄)
  • 药物动力学
  • 动态
  • 生物等效性
  • 生物有效性
  • 全球生物分析测试服务市场,按分子类型、表现和预测细分,2018-2023、2023-2028、2033
  • 低分子
  • 高分子
  • 全球生物分析测试服务市场,按最终用户细分,实际和预测,2018-2023、2023-2028、2033
  • 製药和生物製药公司
  • 合约开发/製造组织
  • 受託研究机构

第 7 章 区域与国家分析

  • 全球生物分析测试服务市场,按地区、实际和预测,2018-2023、2023-2028、2033
  • 全球生物分析测试服务市场,按国家、绩效和预测,2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 生物分析检测服务市场竞争格局
  • 生物分析测试服务市场公司概况
    • CD BioSciences
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Laboratory Corporation of America Holdings(LabCorp)
    • Eurofins Scientific SE

第31章 其他大型创新公司

  • ICON plc
  • PPD Inc.
  • SGS SA
  • WuXi AppTec
  • Syneos Health Inc.
  • STERIS plc
  • Sartorius AG
  • Charles River Laboratories Inc.
  • Intertek Group
  • Covance Inc.
  • PAREXEL International Corporation
  • Element Materials Technology
  • ALS Limited
  • Medpace Holdings Inc.
  • Almac Group

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r15418

Bioanalytical testing services encompass cutting-edge methodologies for quantifying analytes. These services play a pivotal role in identifying and characterizing pharmaceuticals and metabolites within biological fluids such as blood, plasma, serum, urine, or tissue extracts.

Bioanalytical testing services encompass various essential tests, including ADME (absorption, distribution, metabolism, and excretion), pharmacokinetic, pharmacodynamic, bioequivalence, and bioavailability assessments. ADME examines how a chemical undergoes absorption, distribution, metabolism, and excretion within a living organism, crucial for understanding drug processing. It aids in evaluating safety, toxicity, and the viability of drugs, offering precise targets for future research and development endeavors. These testing services analyze both small and large molecules, catering to pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, as well as contract research organizations. They serve as indispensable tools in drug development and assessment, providing vital insights into a compound's behavior within biological systems.

The bioanalytical testing services market research report is one of a series of new reports from The Business Research Company that provides bioanalytical testing services market statistics, including bioanalytical testing services industry global market size, regional shares, competitors with a bioanalytical testing services market share, detailed bioanalytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the bioanalytical testing services industry. This bioanalytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioanalytical testing services market size has grown strongly in recent years. It will grow from $3.23 billion in 2023 to $3.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. Historical growth can be attributed to the globalization of clinical studies, emphasis on pharmacokinetics, implementation of quality control measures, and the increasing focus on personalized medicine.

The bioanalytical testing services market size is expected to see strong growth in the next few years. It will grow to $4.99 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. Anticipated growth in the forecast period is fueled by the expansion of the biopharmaceutical pipeline, increased development of biosimilars, advancements in precision medicine, and the growing complexity of clinical trials. Key trends expected in this period involve the integration of artificial intelligence (AI), comprehensive pharmacokinetic analysis, services for microbiome analysis, adoption of high-throughput technologies, and biological sample analysis.

The growing government initiatives aimed at controlling infectious disease outbreaks are playing a significant role in propelling the expansion of the bioanalytical testing services market. The onset of the COVID-19 pandemic has particularly heightened the demand for bioanalytical testing services, prompting countries worldwide to take proactive measures and increase expenditures to prevent the spread and mitigate the impact of diseases. An illustrative example is the U.S. Department of Health and Human Services' announcement in March 2021, detailing an investment of $10 billion from the American Rescue Plan to bolster screening testing for the safe reopening of schools. Additionally, $2.25 billion was allocated to scale up testing in underserved populations. This increased financial commitment to government initiatives is expected to significantly contribute to the continued growth of the bioanalytical testing services market.

The escalating prevalence of chronic diseases is anticipated to drive the growth of the bioanalytical testing services market in the foreseeable future. Chronic diseases, characterized by enduring illness lasting three months or more and with the potential to worsen over time, necessitate effective diagnostic and monitoring tools. Bioanalytical testing services play a crucial role in identifying and measuring specific biomarkers associated with chronic diseases, aiding in therapeutic drug monitoring to ensure optimal drug levels within the therapeutic range. As an example, the National Library of Medicine reported in January 2023 that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050. Furthermore, according to the World Health Organization's 2022 Highlights in September 2022, 74% of all global deaths, amounting to 41 million annually, result from noncommunicable diseases (NCDs) or chronic diseases. This surge in chronic diseases' prevalence is a key driver propelling the growth of the bioanalytical testing services market.

Major companies within the bioanalytical testing services market are actively pursuing advanced solutions, exemplified by the introduction of technologies such as reverse transcription PCR (RT-PCR) tests, to fortify their market positions. RT-PCR is a laboratory technique involving the conversion of RNA into complementary DNA (cDNA) using the reverse transcriptase enzyme. A case in point is Eurofins Scientific SE, a France-based testing laboratory company, which, in June 2023, launched the NovaType SARS-CoV-2 RT-PCR assay. This clinically validated assay offers a short turnaround time, making it well-suited for the re-testing of millions of positive samples to identify specific virus variants. The NovaType SARS-CoV-2 RT-PCR assay, functioning in real-time, is designed for the qualitative detection of SARS-CoV-2, the virus responsible for COVID-19, and the subsequent identification of specific variants, including B.1.1.7 and B.1.351. This strategic focus on advanced solutions underscores the commitment of major companies to staying at the forefront of technological advancements in the bioanalytical testing services market.

Major companies in the bioanalytical testing services market are strategically investing in the development of advanced testing facilities as part of their efforts to sustain and enhance their market positions. Testing facilities, specialized environments equipped for conducting diverse tests on products, materials, systems, or components, play a pivotal role in ensuring accurate and reliable results. In October 2021, Thermo Fisher Scientific Inc., a prominent US-based biotechnology company, exemplified this strategic focus by launching a State-of-the-Art Bioanalytical Lab. This specialized facility is dedicated to bioanalytical services, involving the analysis of biological samples such as blood or tissue to detect and quantify drugs, metabolites, biomarkers, and other molecules. The lab is equipped with cutting-edge technologies, including liquid chromatography-mass spectrometry (LC-MS), which enables highly sensitive and specific analysis of drugs and other molecules. This emphasis on developing state-of-the-art testing facilities underscores the commitment of major companies to delivering high-quality bioanalytical testing services and maintaining a competitive edge in the market.

In February 2022, Eurofins Scientific, a France-based laboratory service company, announced the acquisition of Genetic Testing Service JSC for an undisclosed amount. This strategic move is expected to facilitate Eurofins' expansion in the clinical genetic testing market and complement its global network of clinical diagnostics laboratories. Genetic Testing Service JSC, based in Vietnam, is a company specializing in genetic testing services, including specialized DNA testing, genealogical DNA tests, and testing for conditions such as cancer and COVID-19.

Major companies operating in the bioanalytical testing services market report are CD BioSciences, Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, ICON PLC, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., STERIS PLC, Sartorius AG, Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Element Materials Technology, ALS Limited, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc., Cinven Ltd. (LGC Limited), Toxikon Inc., Absorption Systems LLC, Lotus Labs Pvt. Ltd., Bioneeds India Private Limited, Vipragen Biosciences Pvt. Ltd., Source BioScience

North America was the largest region in the bioanalytical testing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioanalytical testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioanalytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioanalytical testing services market includes revenues earned by entities by providing services such as method development, high throughput sample analysis, method validation, and pharmacokinetic and toxicokinetic support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioanalytical Testing Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioanalytical testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioanalytical testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioanalytical testing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Test Type: ADME (Absorption, Distribution, Metabolism, And Excretion); Pharmacokinetic; Pharmacodynamic; Bioequivalence; Bioavailability
  • 2) By Molecule Type: Small Molecules; Large Molecules
  • 3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Development And Manufacturing Organizations; Contract Research Organizations
  • Companies Mentioned: CD BioSciences; Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (Labcorp); Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioanalytical Testing Services Market Characteristics

3. Bioanalytical Testing Services Market Trends And Strategies

4. Bioanalytical Testing Services Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Bioanalytical Testing Services Market Size and Growth

  • 5.1. Global Bioanalytical Testing Services Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Bioanalytical Testing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Bioanalytical Testing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioanalytical Testing Services Market Segmentation

  • 6.1. Global Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • ADME (Absorption, Distribution, Metabolism, And Excretion)
  • Pharmacokinetic
  • Pharmacodynamic
  • Bioequivalence
  • Bioavailability
  • 6.2. Global Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Molecules
  • Large Molecules
  • 6.3. Global Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biopharmaceutical Companies
  • Contract Development And Manufacturing Organizations
  • Contract Research Organizations

7. Bioanalytical Testing Services Market Regional And Country Analysis

  • 7.1. Global Bioanalytical Testing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Bioanalytical Testing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioanalytical Testing Services Market

  • 8.1. Asia-Pacific Bioanalytical Testing Services Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioanalytical Testing Services Market

  • 9.1. China Bioanalytical Testing Services Market Overview
  • 9.2. China Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioanalytical Testing Services Market

  • 10.1. India Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioanalytical Testing Services Market

  • 11.1. Japan Bioanalytical Testing Services Market Overview
  • 11.2. Japan Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioanalytical Testing Services Market

  • 12.1. Australia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioanalytical Testing Services Market

  • 13.1. Indonesia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioanalytical Testing Services Market

  • 14.1. South Korea Bioanalytical Testing Services Market Overview
  • 14.2. South Korea Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioanalytical Testing Services Market

  • 15.1. Western Europe Bioanalytical Testing Services Market Overview
  • 15.2. Western Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioanalytical Testing Services Market

  • 16.1. UK Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioanalytical Testing Services Market

  • 17.1. Germany Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioanalytical Testing Services Market

  • 18.1. France Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioanalytical Testing Services Market

  • 19.1. Italy Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19. 2. Italy Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioanalytical Testing Services Market

  • 20.1. Spain Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioanalytical Testing Services Market

  • 21.1. Eastern Europe Bioanalytical Testing Services Market Overview
  • 21.2. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioanalytical Testing Services Market

  • 22.1. Russia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioanalytical Testing Services Market

  • 23.1. North America Bioanalytical Testing Services Market Overview
  • 23.2. North America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioanalytical Testing Services Market

  • 24.1. USA Bioanalytical Testing Services Market Overview
  • 24.2. USA Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioanalytical Testing Services Market

  • 25.1. Canada Bioanalytical Testing Services Market Overview
  • 25.2. Canada Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioanalytical Testing Services Market

  • 26.1. South America Bioanalytical Testing Services Market Overview
  • 26.2. South America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioanalytical Testing Services Market

  • 27.1. Brazil Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioanalytical Testing Services Market

  • 28.1. Middle East Bioanalytical Testing Services Market Overview
  • 28.2. Middle East Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioanalytical Testing Services Market

  • 29.1. Africa Bioanalytical Testing Services Market Overview
  • 29.2. Africa Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioanalytical Testing Services Market Competitive Landscape And Company Profiles

  • 30.1. Bioanalytical Testing Services Market Competitive Landscape
  • 30.2. Bioanalytical Testing Services Market Company Profiles
    • 30.2.1. CD BioSciences
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Laboratory Corporation of America Holdings (LabCorp)
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eurofins Scientific SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Bioanalytical Testing Services Market Other Major And Innovative Companies

  • 31.1. ICON plc
  • 31.2. PPD Inc.
  • 31.3. SGS SA
  • 31.4. WuXi AppTec
  • 31.5. Syneos Health Inc.
  • 31.6. STERIS plc
  • 31.7. Sartorius AG
  • 31.8. Charles River Laboratories Inc.
  • 31.9. Intertek Group
  • 31.10. Covance Inc.
  • 31.11. PAREXEL International Corporation
  • 31.12. Element Materials Technology
  • 31.13. ALS Limited
  • 31.14. Medpace Holdings Inc.
  • 31.15. Almac Group

32. Global Bioanalytical Testing Services Market Competitive Benchmarking

33. Global Bioanalytical Testing Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioanalytical Testing Services Market

35. Bioanalytical Testing Services Market Future Outlook and Potential Analysis

  • 35.1 Bioanalytical Testing Services Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Bioanalytical Testing Services Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Bioanalytical Testing Services Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer